F. Eschwège
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies 45
- Oncology top 2%
- Cancer Diagnosis and Treatment 13
- Ear and Head Tumors 8
- Surgery top 1%
- Head and Neck Surgical Oncology 14
- Salivary Gland Tumors Diagnosis and Treatment 11
- Colorectal and Anal Carcinomas 9
-
- Lung Cancer Treatments and Mutations 8
- Radiation top 2%
- Advanced Radiotherapy Techniques 10
- Co-authors
- P. WibaultP RougierM. van GlabbekeJean-François BossetM. PiérartD. PeiffertF. RoelofsenHarry Bartelink
- Cited by
- OtorhinolaryngologyOncologySurgery
- Journals
- International Journal of Radiation Oncology*Biology*Physics (20 papers)European Journal of Cancer (8 papers)Radiotherapy and Oncology (5 papers)
- Partner nations
- FranceUnited KingdomNetherlands
In The Last Decade
F. Eschwège
103 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Otorhinolaryngology 1.3k
- Oncology 1.4k
- Surgery 2.1k
- Pulmonary and Respiratory Medicine 1.4k
- Radiation 252
Countries citing papers authored by F. Eschwège
This map shows the geographic impact of F. Eschwège's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Eschwège with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Eschwège more than expected).
Fields of papers citing papers by F. Eschwège
This network shows the impact of papers produced by F. Eschwège. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Eschwège. The network helps show where F. Eschwège may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. Eschwège, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 2 | |
| 2 | 2009 | 24 | |
| 3 | 2003 | 1 | |
| 4 | 2002 | 2 | |
| 5 | 2002 | 13 | |
| 6 | The olivacine S16020 enhances the antitumor effect of ionizing radiation without increasing radio-induced mucositis. | 2001 | 8 |
| 7 | 2000 | 22 | |
| 8 | 2000 | 3 | |
| 9 | 1998 | 260 | |
| 10 | 1998 | 3 | |
| 11 | 1998 | 46 | |
| 12 | 1996 | 59 | |
| 13 | 1993 | 44 | |
| 14 | 1993 | 66 | |
| 15 | 1992 | 29 | |
| 16 | 1991 | 8 | |
| 17 | [Focus on research and results of unusual radiotherapy technics (heavy particles, hyperthermia, radiosensitizers)]. | 1989 | 1 |
| 18 | 1989 | 38 | |
| 19 | [Epitheliomas of the glosso-epiglottic fissure. Therapeutic indications and results. Apropos of 80 cases treated at the Institut Gustave-Roussy from 1968 to 1973]. | 1978 | 1 |
| 20 | Ulcères gastriques précoces après radiothérapie. | 1973 | 1 |
About F. Eschwège
F. Eschwège is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 106 papers that have together received 3.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (45 papers), Head and Neck Surgical Oncology (14 papers), Cancer Diagnosis and Treatment (13 papers), Salivary Gland Tumors Diagnosis and Treatment (11 papers), Advanced Radiotherapy Techniques (10 papers), Colorectal and Anal Carcinomas (9 papers), Ear and Head Tumors (8 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Otorhinolaryngology (1.3k citations), Oncology (1.4k citations) and Surgery (2.1k citations). F. Eschwège has collaborated with scholars based in France, United Kingdom and Netherlands. Frequent co-authors include P. Wibault, P Rougier, M. van Glabbeke, Jean-François Bosset, M. Piérart, D. Peiffert, F. Roelofsen, Harry Bartelink, D. González González and Jean Bourhis. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer, Radiotherapy and Oncology, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.